These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 15644992

  • 61. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.
    Roose SP, Nelson JC, Salzman C, Hollander SB, Rodrigues H, Mirtazapine in the Nursing Home Study Group.
    Curr Med Res Opin; 2003; 19(8):737-46. PubMed ID: 14687445
    [Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66. Nefazodone: a new antidepressant.
    Ellingrod VL, Perry PJ.
    Am J Health Syst Pharm; 1995 Dec 15; 52(24):2799-812. PubMed ID: 8748566
    [Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: comparing patients who recently discontinued an SSRI with those on no recent antidepressant treatment.
    Mischoulon D, Opitz G, Kelly K, Fava M, Rosenbaum JF.
    Depress Anxiety; 2004 Dec 15; 19(1):43-50. PubMed ID: 14978785
    [Abstract] [Full Text] [Related]

  • 69. Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression.
    Hicks JA, Argyropoulos SV, Rich AS, Nash JR, Bell CJ, Edwards C, Nutt DJ, Wilson SJ.
    Br J Psychiatry; 2002 Jun 15; 180():528-35. PubMed ID: 12042232
    [Abstract] [Full Text] [Related]

  • 70. Nefazodone treatment of adolescent depression: an open-label study of response and biochemistry.
    Goodnick PJ, Jorge CA, Hunter T, Kumar AM.
    Ann Clin Psychiatry; 2000 Jun 15; 12(2):97-100. PubMed ID: 10907801
    [Abstract] [Full Text] [Related]

  • 71. Nefazodone in the adjunctive therapy of schizophrenia: an open-label exploratory study.
    Rosenberg PB, Rosse RB, Schwartz BL, Deutsch SI.
    Clin Neuropharmacol; 2000 Jun 15; 23(4):222-5. PubMed ID: 11020129
    [Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial.
    Sharpley AL, Williamson DJ, Attenburrow ME, Pearson G, Sargent P, Cowen PJ.
    Psychopharmacology (Berl); 1996 Jul 15; 126(1):50-4. PubMed ID: 8853216
    [Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Polysomnographic sleep effects of fluoxetine and nefazodone on a seasonal affective disorder patient.
    Shen J, Shapiro C.
    Sleep Med; 2002 Nov 15; 3(6):527-8. PubMed ID: 14592151
    [Abstract] [Full Text] [Related]

  • 76. The stability of the Seasonal Pattern Assessment Questionnaire score index over time and the validity compared to classification according to DSM-III-R.
    Christensen EM, Larsen JK, Gjerris A.
    J Affect Disord; 2003 Apr 15; 74(2):167-72. PubMed ID: 12706518
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Seasonal and non-seasonal depression. A comparison of clinical characteristics in Swedish patients.
    Thalén BE, Kjellman BF, Mørkrid L, Wetterberg L.
    Eur Arch Psychiatry Clin Neurosci; 1995 Apr 15; 245(2):101-8. PubMed ID: 7654785
    [Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80. Nefazodone inhibits methylprednisolone disposition and enhances its adrenal-suppressant effect.
    Kotlyar M, Brewer ER, Golding M, Carson SW.
    J Clin Psychopharmacol; 2003 Dec 15; 23(6):652-6. PubMed ID: 14624194
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.